CONMED Corp.

46
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2074101013
USD
44.24
-0.11 (-0.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
CONMED Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
163.00
80.00
-70.00
73.00
1.00
31.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-39.00
-39.00
-90.00
-55.00
-29.00
-23.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
166.00
125.00
33.00
111.00
64.00
95.00
Cash Flow from Investing Activities
-13.00
-20.00
-249.00
-14.00
-13.00
-387.00
Cash Flow from Financing Activities
-151.00
-110.00
225.00
-101.00
-52.00
300.00
Net Cash Inflow / Outflow
0.00
-4.00
8.00
-6.00
1.00
8.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-2.00
0.00
0.00
-1.00
2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CONMED Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
163.029
-18.237
181.00
993.95%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-39.724
-31.007
-8.00
-28.11%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
166.968
129.382
37.00
29.05%
Cash Flow from Investing Activities
-13.084
-390.808
377.00
96.65%
Cash Flow from Financing Activities
-151
237.863
-388.00
-163.48%
Net Cash Inflow / Outflow
0.163
-30.027
30.00
100.54%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-2.721
-6.464
4.00
57.91%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 33.20% vs 275.69% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
166.97
125.35
33.20%